Tokyo retreated marginally in the week to September 22. The Nikkei 225 edged down 1.0%, closing slightly above the 12,000 level, while the Topix index lost 0.7%. A series of shock waves, including the bankruptcy of Lehman Brothers and the merger of Merrill Lynch with Bank of America, caused the Tokyo market to plummet on the first day. Equities showed a modest recovery on the next, helped by the news that the US Federal Reserve had decided to rescue the troubled American International Insurance. Additionally, investors were relieved by the news toward the weekend regarding the possible establishment by the US government of an agency to handle mortgage-backed securities of financial institutions to assist them to improve balance sheets. The pharmaceutical index fell 4.3%, underperforming the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze